Abstract | AIM: To investigate the in-vitro activation of cytotoxic T lymphocytes (CTLs) by fusion of mouse hepatocellular carcinoma (HCC) cells and lymphotactin gene-modified dendritic cells (DCs). METHODS: RESULTS:
Lymphotactin gene could be efficiently transduced to DCs by adenovirus vector and showed an effective biological activity. After fusion, the hybrid DCLptn/H22 cells acquired the phenotypes of both DCLptn and H22 cells. In T cell proliferation assay, flow cytometry showed a very high CD25 expression, and cytokine release assay showed a significantly higher concentration of IFN-gamma and IL-2 in DCLptn/H22 group than in DCLptn, DCLptn+H22, DC/H22 or H22 groups. Cytotoxicity assay revealed that T cells derived from DCLptn/H22 group had much higher anti- tumor activity than those derived from DCLptn, H22, DCLptn+H22, DC/H22 groups. CONCLUSION:
Lymphotactin gene-modified dendritoma induces T-cell proliferation and strong CTL reaction against allogenic HCC cells. Immunization-engineered fusion hybrid vaccine is an attractive strategy in prevention and treatment of HCC metastases.
|
Authors | Xi-Ling Sheng, Hao Zhang |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 13
Issue 44
Pg. 5944-50
(Nov 28 2007)
ISSN: 1007-9327 [Print] United States |
PMID | 17990361
(Publication Type: Journal Article)
|
Chemical References |
- Chemokines, C
- Cytokines
- Interleukin-2 Receptor alpha Subunit
- Xcl1 protein, mouse
|
Topics |
- Adenoviridae
- Animals
- Carcinoma, Hepatocellular
(immunology, metabolism, pathology)
- Cell Fusion
- Cell Line, Tumor
- Cell Proliferation
- Cells, Cultured
- Chemokines, C
(genetics, metabolism)
- Cytokines
(metabolism)
- Dendritic Cells
(immunology, metabolism, pathology)
- Female
- Interleukin-2 Receptor alpha Subunit
(metabolism)
- Liver Neoplasms, Experimental
(immunology, metabolism, pathology)
- Lymphocyte Activation
- Mice
- Mice, Inbred BALB C
- T-Lymphocytes, Cytotoxic
(immunology, pathology, physiology)
- Transduction, Genetic
|